Characterization of the expression and activity of carboxylesterases 1 and 2 from the beagle dog, cynomolgus monkey, and human

ET Williams, JA Bacon, DM Bender, JJ Lowinger… - Drug metabolism and …, 2011 - ASPET
The carboxylesterases (CESs) are a family of serine hydrolases that hydrolyze compounds
containing an ester, amide, or thioester. In humans, two dominant forms, CES1 and CES2 …

A comprehensive functional assessment of carboxylesterase 1 nonsynonymous polymorphisms

X Wang, N Rida, J Shi, AH Wu, BE Bleske… - Drug Metabolism and …, 2017 - ASPET
Carboxylesterase 1 (CES1) is the predominant human hepatic hydrolase responsible for the
metabolism of many clinically important medications. CES1 expression and activity vary …

Discovery of a highly specific and efficacious inhibitor of human carboxylesterase 2 by large-scale screening

YQ Song, XQ Guan, ZM Weng, YQ Wang… - International journal of …, 2019 - Elsevier
Abstract Human carboxylesterase 2 (CES2A), one of the most abundant hydrolases
distributed in human small intestine and colon, play key roles in the hydrolysis of a wide …

Pharmacogenomic assessment of carboxylesterases 1 and 2

S Marsh, M Xiao, J Yu, R Ahluwalia, M Minton… - Genomics, 2004 - Elsevier
Human carboxylesterases 1 and 2 (CES1 and CES2) catalyze the hydrolysis of many
exogenous compounds. Alterations in carboxylesterase sequences could lead to variability …

Identification of di-(2-ethylhexyl) phthalate-induced carboxylesterase 1 in C57BL/6 mouse liver microsomes: purification, cDNA cloning, and baculovirus-mediated …

T Furihata, M Hosokawa, N Koyano, T Nakamura… - Drug metabolism and …, 2004 - ASPET
Several mouse carboxylesterase (CES) isozymes have been identified, but information
about their roles in drug metabolism is limited. In this study, we purified and characterized a …

Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition

ZY Hu, AN Edginton, SC Laizure, RB Parker - Clinical pharmacokinetics, 2014 - Springer
Abstract Background and Objective Human carboxylesterase-1 (CES1) is an enzyme that is
primarily expressed in the liver, where it plays an important role in the metabolism of many …

The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect

Z Merali, S Ross, G Paré - Drug metabolism and drug interactions, 2014 - degruyter.com
Abstract Human carboxylesterase 1 (CES1) and carboxylesterase 2 (CES2) are serine
esterases responsible for the hydrolysis of ester and amide bonds present in a number of …

[HTML][HTML] Carboxylesterase 1 genes: systematic review and evaluation of existing genotyping procedures

HB Rasmussen, MB Madsen… - Drug Metabolism and …, 2018 - degruyter.com
Abstract The carboxylesterase 1 gene (CES1) encodes a hydrolase that metabolizes
commonly used drugs. The CES1-related pseudogene, carboxylesterase 1 pseudogene 1 …

Pharmacometabolomics informs about pharmacokinetic profile of methylphenidate

R Kaddurah‐Daouk, T Hankemeier… - CPT …, 2018 - Wiley Online Library
Carboxylesterase 1 (CES1) metabolizes methylphenidate and other drugs. CES1 gene
variation only partially explains pharmacokinetic (PK) variability. Biomarkers predicting the …

Effects of alcohol on human carboxylesterase drug metabolism

RB Parker, ZY Hu, B Meibohm, SC Laizure - Clinical pharmacokinetics, 2015 - Springer
Abstract Background and Objective Human carboxylesterase-1 (CES1) and human
carboxylesterase-2 (CES2) play an important role in metabolizing many medications …